Categories
Jump to navigation
Jump to search
The following categories exist on the wiki, and may or may not be unused. Also see wanted categories.
(first | last) View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Malignant solid neoplasm, BRAF-mutated regimens (1 member)
- Malignant solid neoplasm, EGFR-mutated medications (1 member)
- Malignant solid neoplasm, EGFR-mutated regimens (1 member)
- Malignant solid neoplasm, ERBB2-mutated medications (5 members)
- Malignant solid neoplasm, ERBB2-mutated regimens (1 member)
- Malignant solid neoplasm, ERBB3-mutated medications (1 member)
- Malignant solid neoplasm, ERBB3-mutated regimens (1 member)
- Malignant solid neoplasm, MSI-H or dMMR medications (5 members)
- Malignant solid neoplasm, MSI-H or dMMR regimens (1 member)
- Malignant solid neoplasm, NTRK-mutated medications (2 members)
- Malignant solid neoplasm, NTRK-mutated regimens (1 member)
- Malignant solid neoplasm, RET-mutated medications (1 member)
- Malignant solid neoplasm, RET-mutated regimens (1 member)
- Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) medications (1 member)
- Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) regimens (1 member)
- Malignant solid neoplasm, TMB-H medications (1 member)
- Malignant solid neoplasm, TMB-H regimens (1 member)
- Mantle cell lymphoma medications (44 members)
- Mantle cell lymphoma medications (investigational) (2 members)
- Mantle cell lymphoma regimens (3 members)
- Marginal zone lymphoma medications (23 members)
- Marginal zone lymphoma medications (historic) (1 member)
- Marginal zone lymphoma regimens (2 members)
- Marginal zone lymphomas (3 members)
- Matrix metalloproteinase inhibitors (1 member)
- Mediastinal gray-zone lymphoma medications (10 members)
- Mediastinal gray-zone lymphoma regimens (1 member)
- Medications by manufacturing method (1 member)
- Medullary thyroid cancer medications (0 members)
- Medulloblastoma medications (12 members)
- Medulloblastoma medications (historic) (1 member)
- Medulloblastoma regimens (2 members)
- Megakaryocyte growth factors (5 members)
- Melanoma medications (35 members)
- Melanoma medications (historic) (9 members)
- Melanoma medications (investigational) (0 members)
- Melanoma regimens (8 members)
- Meningioma regimens (2 members)
- Merck product (1 member)
- Merkel cell carcinoma medications (3 members)
- Merkel cell carcinoma regimens (2 members)
- Mesothelioma medications (3 members)
- Mesothelioma medications (investigational) (1 member)
- Mesothelioma regimens (3 members)
- Mesotheliomas (2 members)
- Microtubule inhibitors (23 members)
- Molecular chaperone inhibitors (2 members)
- Mucositis prevention (2 members)
- Multiple myeloma medications (38 members)
- Multiple myeloma medications (historic) (11 members)